You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股異動 | 國藥控股跌逾4% 遭小摩減持847.64萬股涉資約1.87億港元
格隆匯 03-12 10:26
格隆匯3月12日丨國藥控股(1099.HK)現報18.46港元,跌4.45%,暫成交1億港元,最新總市值576億港元。根據聯交所最新權益披露資料顯示,國藥控股於3月6日遭JPMorgan Chase & Co.以每股均價22.0036港元減持H股好倉約847.64萬股,涉資約1.87億港元。減持後,其最新持H股好倉數目約為1.0171億股,持H股好倉比例由8.21%降至7.57%。公司3月8日晚間曾發盈警公告稱,基於現有的財務和經營信息,以及外部市場環境和疫情所處階段,董事會預計,集團截至2020年3月31日止一季度業績可能出現較大幅度同比下降。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account